Platelet-rich fibrin is a bioscaffold and reservoir of growth factors for tissue regeneration

Tissue Engineering - Part A

Volumn 17, Issue 3-4, 2011, Pages 349-359

  Kang, Young Ho ^a   Jeon, Soung Hoo ^a   Park, Joo Young ^a   Chung, Jong Hoon ^b   Choung, Yun Hoon ^c   Choung, Han Wool ^a   Kim, Eun Suk ^d   Choung, Pill Hoon ^a  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; ENZYME INHIBITION; MEDICINE; MICROSTRUCTURE; MINERALOGY; PEPTIDES; SCANNING ELECTRON MICROSCOPY; STEM CELLS; TISSUE;

ALVEOLAR BONES; BIO-SCAFFOLDS; BLOOD CELLS; CLINICAL MEDICINE; CYTOKINES; GROWTH FACTOR; IMMUNO-HISTOLOGICAL STAINING; IMMUNOBLOTS; IN-VITRO; MATRIX METALLOPROTEINASE-9; MINERALIZATION ASSAYS; MOUSE CALVARIA; PLATELET RICH PLASMA; PROTEOMES; SCANNING ELECTRON MICROSCOPY IMAGE; TISSUE REGENERATION; TRANSFORMING GROWTH FACTORS;

PLATELETS;

FIBRIN; SIGNAL PEPTIDE; TISSUE SCAFFOLD;

ABSORPTION; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BONE REGENERATION; CELL CULTURE; HUMAN; INSTRUMENTATION; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SKULL FRACTURE; THROMBOCYTE RICH PLASMA; TISSUE REGENERATION; TREATMENT OUTCOME;

ABSORPTION; ANIMALS; BONE REGENERATION; CELLS, CULTURED; FIBRIN; GUIDED TISSUE REGENERATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; PLATELET-RICH PLASMA; SKULL FRACTURES; TISSUE SCAFFOLDS; TREATMENT OUTCOME;

EID: 79551554162     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0327     Document Type: Article

References (40)

1. Marx, R.E., Carlson, E.R., Eichstaedt, R.M., Schimmele, S.R., Strauss, J.E., and Georgeff, K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85, 638, 1998.
2. Dohan, D.M., Choukroun, J., Diss, A., Dohan, S.L., Dohan, A.J., Mouhyi, J., and Gogly, B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101, e37, 2006.
3. Mazor, Z., Horowitz, R.A., Del Corso, M., Prasad, H.S., Rohrer, M.D., and Dohan Ehrenfest, D.M. Sinus floor augmentation with simultaneous implant placement using Choukroun's platelet-rich fibrin as the sole grafting material: a radiologic and histologic study at 6 months. J Periodontol 80, 2056, 2009.
4. Choukroun, J., Diss, A., Simonpieri, A., Girard, M.O., Schoeffler, C., Dohan, S.L., Dohan, A.J., Mouhyi, J., and Dohan, D.M. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101, e56, 2006.
5. Choukroun, J., Diss, A., Simonpieri, A., Girard, M.O., Schoeffler, C., Dohan, S.L., Dohan, A.J., Mouhyi, J., and Dohan, D.M. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101, 299, 2006.
6. Dohan, D.M., Choukroun, J., Diss, A., Dohan, S.L., Dohan, A.J., Mouhyi, J., and Gogly, B.L. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101, e51, 2006.
7. Dohan, D.M., Choukroun, J., Diss, A., Dohan, S.L., Dohan, A.J., and Mouhyi, J. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101, e45, 2006.
8. Dohan Ehrenfest, D.M., de Peppo, G.M., Doglioli, P., and Sammartino, G. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 27, 63, 2009.
9. Lorenzo, J., Horowitz, M., and Choi, Y. Osteoimmunology: interactions of the bone and immune system. Endocr Rev 29, 403, 2008.
10. Pierce, G.F., Mustoe, T.A., Altrock, B.W., Deuel, T.F., and Thomason, A. Role of platelet-derived growth factor in wound healing. J Cell Biochem 45, 319, 1991.
11. Bolander, M.E. Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 200, 165, 1992.
12. Cromack, D.T., Porras-Reyes, B., and Mustoe, T.A. Current concepts in wound healing: growth factor and macrophage interaction. J Trauma 30, S129, 1990.
13. Dohan Ehrenfest, D.M., de Peppo, G.M., Doglioli, P., and Sammartino, G. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 27, 63, 2009.
14. Dohan, D.M., and Choukroun, J. PRP, cPRP, PRF, PRG, PRGF, FC?How to find your way in the jungle of platelet concentrates? OraSurg Oral Med Oral Pathol Oral Radiol Endod 103, 305, 2007.
15. Dugrillon, A., Eichler, H., Kern, S., and Klü ter, H. Auto-logous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration. Int J Oral Maxillofac Surg 31, 615, 2002.
16. Marx, R.E., Carlson, E.R., Eichstaedt, R.M., Schimmele, S.R., Strauss, J.E., and Georgeff, K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85, 638, 1998.
17. Shanaman, R., Filstein, M.R., and Danesh-Meyer, M.J. Localized ridge augmentation using GBR and platelet-rich plasma: case reports. Int J Periodontics Restorative Dent 21, 345, 2001.
18. Schlegel, K.A., Donath, K., Rupprecht, S., Falk, S., Zimmer-mann, R., Felszeghy, E., and Wiltfang, J. De novo bone formation using bovine collagen and platelet-rich plasma. Biomaterials 25, 5387, 2004.
19. Thorwarth, M., Rupprecht, S., Falk, S., Felszeghy, E., Wiltfang, J., and Schlegel, K.A. Expression of bone matrix proteins during de novo bone formation using a bovine collagen and platelet-rich plasma (PRP)-an immunohistochemical analysis. Biomaterials 26, 2575, 2005.
20. He, L., Lin, Y., Hu, X., Zhang, U., and Wu, H. Comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108, 707, 2009.
21. O'Connell, S.M. Safety issues associated with platelet-rich fibrin method. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103, 587, 2007.
22. Cowan, C.M., Shi, Y.Y., Aalami, O.O., Chou, Y.F., Mari, C., Thomas, R., Quarto, N., Contag, C.H., Wu, B., and Long-aker, M.T. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 22, 560, 2004.
23. Sahni, A., Odrljin, T., and Francis, C.W. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem 273, 7554, 1998.
24. Dohan Ehrenfest, D.M., Rasmusson, L., and Albrektsson, T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 27, 158, 2009.
25. Yu, Q., and Stamenkovic, I. Localization of matrix metallo-proteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13, 35, 1999.
26. Karadag, A., Fedarko, N.S., and Fisher, L.W. Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44. Cancer Res 65, 11545, 2005.
27. Desai, B., Rogers, M.J., and Chellaiah, M.A. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells. Mol Cancer 6, 18, 2007.
28. Samanna, V., Ma, T., Mak, T.W., Rogers, M., and Chellaiah, M.A. Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function. J Cell Physiol 213, 710, 2007.
29. Dohan Ehrenfest, D.M., Rasmusson, L., and Albrektsson, T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 27, 158, 2009.
30. Whitman, D.H., Berry, R.L., and Green, D.M. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 55, 1294, 1997.
31. Dohan Ehrenfest, D.M., Diss, A., Odin, G., Doglioli, P., Hippolyte, M.P., and Charrier, J.B. In vitro effects of Choukroun's PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108, 341, 2009.
32. Aroca, S., Keglevich, T., Barbieri, B., Gera, I., and Etienne, D. Clinical evaluation of a modified coronally advanced flap alone or in combination with a platelet-rich fibrin membrane for the treatment of adjacent multiple gingival recessions: a 6-month study. J Periodontol 80, 244, 2009.
33. Wolberg, A.S. Thrombin generation and fibrin clot structure. Blood Rev 21, 131, 2007.
34. Van Hinsbergh, V.W., Collen, A., and Koolwijk, P. Role of fibrin matrix in angiogenesis. Ann NY Acad Sci 936, 426, 2001.
35. Ouyang, H., McCauley, L.K., Berry, J.E., D'Errico, J.A., Strayhorn, C.L., and Somerman, M.J. Response of immortalized murine cementoblasts/periodontal ligament cells to parathyroid hormone and parathyroid hormone-related protein in vitro. Arch Oral Biol 45, 293, 2000.
36. Ohno, S., Doi, T., Fujimoto, K., Ijuin, C., Tanaka, N., Tanimoto, K., Honda, K., Nakahara, M., Kato, Y., and Tanne, K. RGD-CAP (betaig-h3) exerts a negative regulatory function on mineralization in the human periodontal ligament. J Dent Res 81, 822, 2002.
37. Marcopoulou, C.E., Vavouraki, H.N., Dereka, X.E., and Vrotsos, I.A. Proliferative effect of growth factors TGF-beta1, PDGF-BB and rhBMP-2 on human gingival fibroblasts and periodontal ligament cells. J Int Acad Periodontol 5, 63, 2003.
38. Thalmann, G.N., Sikes, R.A., Devoll, R.E., Kiefer, J.A., Markwalder, R., Klima, I., Farach-Carson, C.M., Studer, U.E., and Chung, L.W. Osteopontin: possible role in prostate cancer progression. Clin Cancer Res 5, 2271, 1999.
39. Ishimaru, H., Kageyama, Y., Hayashi, T., Nemoto, T., Eishi, Y., and Kihara, K. Expression of matrix metalloproteinase-9 and bombesin/gastrin- releasing peptide in human prostate cancers and their lymph node metastases. Acta Oncol 41, 289, 2002.
40. Hara, T., Miyazaki, H., Lee, A., Tran, CP., and Reiter, R.E. Androgen receptor and invasion in prostate cancer. Cancer Res 68, 1128, 2008.